The Market is expecting a CR by the way this is trading. The previous CR was extremely poorly mismanaged. You would think that they are going to be much more careful with the next CR and who they allow to participate considering the sellers from the previous CR have been major contributors to this stock price decimation.
@tinyteddy your post and opinions on this forum are highly regarded . This quarterly is going to be very interesting to see if they can continue the strong momentum. The previous quarterly revenue was more than the previous four quarterlies combined. . When Biotech related stocks especially those that have had stock prices decimated release strong clinical trial data , they can multi bag. Whilst I do not expect that here due to the SOI , a stock price closer to a cent is achievable and with momentum and volume , this could give the options to be in the money a real chance. The timing of the next CR can either assist or destroy this theory.
OSL Price at posting:
0.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)